William Blair & Company
BPMC

William Blair & Company’s Blueprint Medicines BPMC Stock Holding History

William Blair & Company’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6,512
Closed -$602K – 1823
2024
Q3 		$602K Buy
6,512
+465
+8% +$46.2K ﹤0.01% 1063
2024
Q2 		$652K Sell
6,047
-569
-9% -$57K ﹤0.01% 1018
2024
Q1 		$628K Hold
6,616
– – ﹤0.01% 1029
2023
Q4 		$610K Buy
6,616
+1,249
+23% +$80.9K ﹤0.01% 1022
2023
Q3 		$270K Hold
5,367
– – ﹤0.01% 1282
2023
Q2 		$339K Buy
+5,367
New +$292K ﹤0.01% 1204
2022
Q4 		– Sell
-3,530
Closed -$233K – 1827
2022
Q3 		$233K Buy
+3,530
New +$227K ﹤0.01% 1328
2022
Q2 		– Sell
-3,851
Closed -$246K – 1868
2022
Q1 		$246K Sell
3,851
-2,105
-35% -$151K ﹤0.01% 1436
2021
Q4 		$638K Buy
5,956
+401
+7% +$41.9K ﹤0.01% 1119
2021
Q3 		$571K Buy
5,555
+2,486
+81% +$232K ﹤0.01% 1108
2021
Q2 		$270K Hold
3,069
– – ﹤0.01% 1387
2021
Q1 		$298K Sell
3,069
-197
-6% -$19.7K ﹤0.01% 1332
2020
Q4 		$366K Buy
+3,266
New +$344K ﹤0.01% 1182

Other funds holding BPMC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

William Blair & Company's BPMC Position: Q4 2024 in Review

William Blair & Company sold out of Blueprint Medicines (BPMC) in Q4 2024, closing a stake of 6,512 shares — an estimated $602K sold.

William Blair & Company first reported a position in BPMC in Q4 2020 and held it in 13 quarters. The position peaked at $652K in Q2 2024. 345 funds tracked by Wall St. Rank hold BPMC as of Q4 2024.

  • William Blair & Company reported no remaining Blueprint Medicines position as of Q4 2024 after selling out during the quarter.
  • William Blair & Company sold 6,512 Blueprint Medicines shares in Q4 2024, an estimated $602K.
  • William Blair & Company first reported a position in Blueprint Medicines in Q4 2020 and held it in 13 quarters.
  • William Blair & Company's Blueprint Medicines position peaked at $652K in Q2 2024.
  • 345 funds tracked by Wall St. Rank held Blueprint Medicines as of Q4 2024.

Based on William Blair & Company's 13F filing for Q4 2024, filed 12 Feb 2025.